The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug‐Resistant E. coli Infections in the United States
Open accessAbstract
BACKGROUND: Escherichia coli sequence type ST131 (O25:H4), associated with the CTX-M-15 extended-spectrum beta-lactamase, has emerged internationally as a multidrug-resistant pathogen but has received little attention in the United States. METHODS: From the SENTRY and Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) surveillance programs, 127 E. coli clinical isolates from hospitalized patients across the United States in 2007, stratified by extended-spectrum cephalosporin and fluoroquinolone phenotype and bla(CTX-M-15) genotype, were assessed for phylogenetic group, ST131 status, susceptibility profile, virulence genotype, gyrA and parC sequence, and pulsed-field gel electrophoresis profile. RESULTS: The 54 identified ST131 isolates (all fluoroquinolone resistant) accounted for an estimated 17% of the source populations, including 67%-69% of isolates resistant to extended-spectrum cephalosporins or fluoroquinolones, 55% of those resistant to both fluoroquinolones and trimethoprim-sulfamethoxazole, and 52% of multidrug-resistant isolates. Their distinctive virulence profiles were more extensive compared with other antimicrobial-resistant isolates but similarly extensive compared with antimicrobial-susceptible isolates. Pulsed-field profiling suggested ongoing dissemination among locales, with concentration of bla(CTX-M-15) within specific ST131 lineages. A historical ST131 isolate lacked the 2007 ST131 isolates' conserved fluoroquinolone resistance-associated single-nucleotide polymorphisms in gyrA and parC. CONCLUSIONS: A single E. coli clonal group, ST131, probably caused the most significantly antimicrobial-resistant E. coli infections in the United States in 2007, thereby constituting an important new public health threat. Enhanced virulence and/or antimicrobial resistance compared with other E. coli, plus ongoing dissemination among locales, may underlie ST131's success. Urgent investigation of the sources and transmission pathways of ST131 is needed to inform mitigation efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
genalex 6: genetic analysis in Excel. Population genetic software for teaching and research
PEAKALL, R., & SMOUSE, P. E. (2006) · Molecular Ecology Notes · doi:10.1111/j.1471-8286.2005.01155.x · Cited by 16,589
The Complete Genome Sequence of Escherichia coli K-12
Blattner, F. R., Plunkett, G., Bloch, C. A., Perna, N. T., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C. K., Mayhew, G. F., et al. (1997) · Science · doi:10.1126/science.277.5331.1453 · Cited by 7,452
Rapid and Simple Determination of the Escherichia coli Phylogenetic Group
Clermont, O., Bonacorsi, S., & Bingen, E. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.10.4555-4558.2000 · Cited by 2,645
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Ribot, E. M., Fair, M. A., Gautom, R., Cameron, D. N., Hunter, S. B., Swaminathan, B., & Barrett, T. J. (2006) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2006.3.59 · Cited by 1,577
Johnson, J. R., & Stell, A. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315217 · Cited by 1,269
Self-citationWarren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999) · Clinical Infectious Diseases · doi:10.1086/520427 · Cited by 1,188
Self-citationThe CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Self-citationCoque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Russo, T. A., & Johnson, J. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315418 · Cited by 652
Self-citationClermont, O., Dhanji, H., Upton, M., Gibreel, T., Fox, A., Boyd, D., Mulvey, M. R., Nordmann, P., Ruppe, E., Sarthou, J. L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp194 · Cited by 357
Clermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn084 · Cited by 274
Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Self-citationJohnson, J. R., Kuskowski, M. A., Owens, K., Gajewski, A., & Winokur, P. L. (2003) · The Journal of Infectious Diseases · doi:10.1086/377455 · Cited by 246
Self-citationLewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 231
Molecular Epidemiology and Phylogenetic Distribution of the Escherichia coli pks Genomic Island
Johnson, J. R., Johnston, B., Kuskowski, M. A., Nougayrede, J.-P., & Oswald, E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00949-08 · Cited by 194
Self-citationCagnacci, S., Gualco, L., Debbia, E., Schito, G. C., & Marchese, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Johnson, J. R., Clermont, O., Menard, M., Kuskowski, M. A., Picard, B., & Denamur, E. (2006) · The Journal of Infectious Diseases · doi:10.1086/507305 · Cited by 161
Self-citationLeflon‐Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M.-C., Duportail, F., Heym, B., Bingen, É., & Nicolas-Chanoine, M.-H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3736-3742.2004 · Cited by 125
Endemic and Epidemic Lineages ofEscherichia colithat Cause Urinary Tract Infections
Manges, A. R., Tabor, H., Tellis, P. A., Vincent, C., & Tellier, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1410.080102 · Cited by 115
Castanheira, M., Mendes, R. E., Rhomberg, P. R., & Jones, R. N. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0827 · Cited by 88
Self-citationVigil, K. J., Johnson, J. R., Johnston, B., Kontoyiannis, D. P., Mulanovich, V. E., RAAD, I. I., DuPont, H. L., & Adachi, J. A. (2009) · Clinical Infectious Diseases · doi:10.1086/649866 · Cited by 73
Self-citationClonal relationships among bloodstream isolates of Escherichia coli
Maslow, J. N., Whittam, T. S., Gilks, C. F., Wilson, R. A., Mulligan, M. E., Adams, K. S., & Arbeit, R. D. (1995) · Infection and Immunity · doi:10.1128/iai.63.7.2409-2417.1995 · Cited by 72
Ender, P. T., Gajanana, D., Johnston, B., Clabots, C., Tamarkin, F. J., & Johnson, J. R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01361-09 · Cited by 71
Self-citation
Cited by
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Metadata
- Authors
- Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08
- Volume
- 51
- Issue
- 3
- Pages
- 286-294
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2160213626
- Cited by
- 510
- References
- 26
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.